Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
shareholder activism
Pharma
Turbulent times at Aurinia with renewed investor activism
Four Aurinia board directors—including CEO Peter Greenleaf—and the proposed exec compensation recently failed to win majority shareholder support.
Angus Liu
Aug 13, 2024 11:30am
AZ's pay proposal for Pascal Soriot passes at investor meeting
Apr 12, 2024 9:40am
Once again, AstraZeneca encounters CEO pay pushback
Apr 1, 2024 12:57pm
Catalent turns to Elliott after 2023 earnings disappoint
Aug 30, 2023 9:41am
Sarissa Capital fights for spots on Alkermes' board
Jun 12, 2023 9:45am
AZ's CEO Pascal Soriot fights investor skepticism—yet again
Apr 27, 2023 10:25am
